Midodrine in treatment of post coronary revascularization vasoplagia; pilot, open label, assessor blinded randomized clinical trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Treatment of acute heart failure - Pharmacological & non-pharmacological Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by